
Results
9
Large established companies which pay a dividend.
9 companies
Sanofi
Market Cap: €90.1b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€75.08
7D
2.2%
1Y
-9.6%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,126.50
7D
-1.5%
1Y
52.8%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,724.00
7D
-3.4%
1Y
6.8%
Krka d. d
Market Cap: €7.6b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€250.50
7D
-2.7%
1Y
29.8%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,560.00
7D
0.2%
1Y
3.1%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,359.00
7D
0.4%
1Y
51.1%
Abbott India
Market Cap: ₹540.5b
Operates as a pharmaceutical company in India.
500488
₹25,567.00
7D
-0.1%
1Y
-27.8%
China Resources Sanjiu Medical & Pharmaceutical
Market Cap: CN¥37.4b
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
CN¥23.23
7D
-0.5%
1Y
-24.8%
Livzon Pharmaceutical Group
Market Cap: CN¥23.2b
Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.
000513
CN¥29.65
7D
-0.03%
1Y
-17.8%